NEW YORK (GenomeWeb News) – Affymetrix and China’s Zhejiang University will jointly develop clinical applications for Affy's GeneChip technology, Affymetrix said today.
The partners will also establish a joint laboratory to support researchers from Zhejiang University and six affiliated hospitals that use the GeneChip to analyze genomic information across large patient samples, Affy said.
Under the agreement, the university’s Zhejiang California Nanosystem Institute will use the array platform for certain of its research projects, beginning with cancer, newborn genetic diseases, and infectious diseases.
According to Affymetrix, the agreement is its first translational medicine collaboration in China.
Financial details were not disclosed.